The disruption of glycosylation δT3 in these two cancer cell lines led to lower PD-L1 expression and exosomal secretion and reduction of PD-L1/PD-1 interaction as seen in the T-cell killing assay using coculture of Jurkat T-cells and δT3 pretreated DU145 cells. This evidence concerns the gene PDCD1 and cancer.